Highlights
- •The prevalence of drug-related deaths was 0.74% of hospital admissions, and 0.47% in the case of hospital-acquired drugs.
- •The risk factors associated with drug-related deaths were age, admission at the intensive care unit, and length of stay.
- •The AUC ROC value was 0.82 showing a good predictive potential for the risk factors studied.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Proposal for a regulation amending, as regards pharmacovigilance of medicinal products for human use. Regulation (EC) no 726/2004.in: Impact Assessment. 2008 ([Available from: http://ec.europa.eu/health/files/pharmacos/pharmpack_ 12_2008/pharmacovigilance-ia-vol1_en.pdf. Accessed 9 Aug 2019])
- Epidemiology of adverse drug reactions in Europe: a review of recent observational studies.Drug Saf. 2015; 38: 437-453
- Drug-related mortality among inpatients: a retrospective observational study.Eur J Clin Pharmacol. 2016; 72: 731-736
- Patterns of adverse drug reaction in the medical wards of a teaching hospital: a prospective observational cohort study.Curr Drug Saf. 2016; 11: 164-171
- Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.Br J Clin Pharmacol. 2011; 71: 95-104
- Adverse drug reactions in critical care settings: a systematic review.Curr Drug Saf. 2017; 12: 147-161
- Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden.Pharmacoepidemiol Drug Saf. 2017; 26: 335-343
Article info
Publication history
Published online: October 17, 2019
Accepted:
September 14,
2019
Received:
August 28,
2019
Identification
Copyright
© 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
